All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
SLNO / Soleno Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
GMED / Globus Medical, Inc.
|
|
|
|
|
|
|
|
NUVB / Nuvation Bio Inc.
|
|
|
|
|
|
|
|
CRGX / CARGO Therapeutics, Inc.
|
|
|
|
|
|
|
|
ACOG / Alpha Cognition Inc.
|
|
|
|
|
|
|
|
QTTB / Q32 Bio Inc.
|
|
|
|
|
|
|
|
VTRS / Viatris Inc.
|
|
|
|
|
|
|
|
OGN / Organon & Co.
|
|
|
|
|
|
|
|
MESO / Mesoblast Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CI / The Cigna Group
|
|
|
|
|
|
|
|
HAE / Haemonetics Corporation
|
|
|
|
|
|
|
|
CCCC / C4 Therapeutics, Inc.
|
|
|
|
|
|
|
|
SNY / Sanofi - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
NXTC / NextCure, Inc.
|
|
|
|
|
|
|
|
AQST / Aquestive Therapeutics, Inc.
|
|
|
|
|
|
|
|
NMRA / Neumora Therapeutics, Inc.
|
|
|
|
|
|
|
|
PMVP / PMV Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ANIP / ANI Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SEPN / Septerna, Inc.
|
|
|
|
|
|
|
|
AVTX / Avalo Therapeutics, Inc.
|
|
|
|
|
|
|
|
AVR / Anteris Technologies Global Corp.
|
|
|
|
|
|
|
|
MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
ERAS / Erasca, Inc.
|
|
|
|
|
|
|
|
AVNS / Avanos Medical, Inc.
|
|
|
|
|
|
|
|
DRUG / Bright Minds Biosciences Inc.
|
|
|
|
|
|
|
|
ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
TYRA / Tyra Biosciences, Inc.
|
|
|
|
|
|
|
|
ANNX / Annexon, Inc.
|
|
|
|
|
|
|
|
SVRA / Savara Inc.
|
|
|
|
|
|
|
|
VXRT / Vaxart, Inc.
|
|
|
|
|
|
|
|
PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
PRAX / Praxis Precision Medicines, Inc.
|
|
|
|
|
|
|
|
VTYX / Ventyx Biosciences, Inc.
|
|
|
|
|
|
|
|
MODD / Modular Medical, Inc.
|
|
|
|
|
|
|
|
TFX / Teleflex Incorporated
|
|
|
|
|
|
|
|
ICLR / ICON Public Limited Company
|
|
|
|
|
|
|
|
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
|
|
|
|
|
|
|
|
ZBH / Zimmer Biomet Holdings, Inc.
|
|
|
|
|
|
|
|
MMS / Maximus, Inc.
|
|
|
|
|
|
|
|
ATXS / Astria Therapeutics, Inc.
|
|
|
|
|
|
|
|
VIR / Vir Biotechnology, Inc.
|
|
|
|
|
|
|
|
AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
DNTH / Dianthus Therapeutics, Inc.
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
HUMAW / Humacyte, Inc. - Equity Warrant
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
APRE / Aprea Therapeutics, Inc.
|
|
|
|
|
|
|
|
TERN / Terns Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
LH / Labcorp Holdings Inc.
|
|
|
|
|
|
|
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
IRON / Disc Medicine, Inc.
|
|
|
|
|
|
|
|
ALGS / Aligos Therapeutics, Inc.
|
|
|
|
|
|
|
|
OVID / Ovid Therapeutics Inc.
|
|
|
|
|
|
|
|
EMBC / Embecta Corp.
|
|
|
|
|
|
|
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
NYXH / Nyxoah SA
|
|
|
|
|
|
|
|
AORT / Artivion, Inc.
|
|
|
|
|
|
|
|
TELA / TELA Bio, Inc.
|
|
|
|
|
|
|
|
FHTX / Foghorn Therapeutics Inc.
|
|
|
|
|
|
|
|
CNTX / Context Therapeutics Inc.
|
|
|
|
|
|
|
|
ETNB / 89bio, Inc.
|
|
|
|
|
|
|
|